Cyclobenzaprine is used in the treatment of muscle spasm; sciatica; fibromyalgia; chronic myofascial pain; migraine , and belongs to the drug class skeletal muscle relaxants. There is no proven risk in humans during pregnancy. Cyclobenzaprine is not subject to the Controlled Substances Act.
Soma is used in the treatment of muscle spasm; nocturnal leg cramps and belongs to the drug class skeletal muscle relaxants. Risk cannot be ruled out during pregnancy. Soma has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
- Soma Information for Consumers
- Soma Information for Healthcare Professionals (includes dosage details)
- Side Effects of Soma (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 24 Jan 2010 • 1 answer
Posted 22 Apr 2011 • 2 answers
Posted 12 Oct 2011 • 9 answers
Posted 19 Dec 2013 • 1 answer
Posted 10 Apr 2014 • 1 answer